TRADD is critical for resistance to TRAIL-induced cell death through NF-κB activation

FEBS Letters

Volumn 585, Issue 14, 2011, Pages 2144-2150

  Kim, Joo Young ^a   Lee, Ju Yeon ^a   Kim, Dong Gun ^a   Koo, Gi Bang ^a   Yu, Je Wook ^b   Kim, You Sun ^a  

^a Ajou University School of Medicine   (South Korea)

^b Myong Ji University   (South Korea)

Author keywords

Cell death; NF B; TRADD; TRAIL

Indexed keywords

DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL DEATH; CELL STRAIN HEPG2; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, KNOCKOUT; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79960341239     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.05.034     Document Type: Article

References (23)

1. Y.L. Pobezinskaya, Y.S. Kim, S. Choksi, M.J. Morgan, T. Li, C. Liu, and Z. Liu The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors Nat. Immunol. 9 2008 1047 1054
2. G. Chen, and D. Goeddel TNF-R1 signaling: a beautiful pathway Science's STKE 296 2002 1634
3. H. Hsu, H. Shu, M. Pan, and D. Goeddel TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 84 1996 299 308 (Pubitemid 26042835)
4. H. Hsu, J. Xiong, and D. Goeddel The TNF receptor 1-associated protein TRADD signals cell death and NF-[kappa] B activation Cell 81 1995 495 504
5. O. Micheau, and J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190 (Pubitemid 36936912)
6. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ. 10 2003 45 65 (Pubitemid 36511832)
7. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat. Rev. Cancer 8 2008 782 798
8. W.H. Hu, H. Johnson, and H.B. Shu Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways J. Biol. Chem. 274 1999 30603 30610
9. F. Igney, and P. Krammer Death and anti-death: tumour resistance to apoptosis Nat. Rev. Cancer 2 2002 277 288 (Pubitemid 37328781)
10. L. Zhang, and B. Fang Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene therapy 12 2004 228 237
11. Y. Lin, A. Devin, A. Cook, M.M. Keane, M. Kelliher, S. Lipkowitz, and Z.G. Liu The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase Mol. Cell Biol. 20 2000 6638 6645
12. I. Jeremias, and K.M. Debatin TRAIL induces apoptosis and activation of NFkappaB Eur. Cytokine Netw. 9 1998 687 688 (Pubitemid 29033939)
13. I. Jeremias, C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K.M. Debatin Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells Blood 91 1998 4624 4631 (Pubitemid 28270311)
14. N. Harper, S.N. Farrow, A. Kaptein, G.M. Cohen, and M. MacFarlane Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases J. Biol. Chem. 276 2001 34743 34752
15. G.L. Johnson, and R. Lapadat Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298 2002 1911 1912 (Pubitemid 35425238)
16. L. Chang, and M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40 (Pubitemid 32225829)
17. J.M. Lluis TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL PLoS One 5 2010 e8620
18. T.S. Jani, J. DeVecchio, T. Mazumdar, A. Agyeman, and J.A. Houghton Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin J. Biol. Chem. 285 2010 19162 19172
19. X. Cao, Y.L. Pobezinskaya, M.J. Morgan, and Z.G. Liu The role of TRADD in TRAIL-induced apoptosis and signaling FASEB J. 25 2011 1353 1358
20. M.J. Morgan, Y.S. Kim, and Z.G. Liu Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complex J. Immunol. 183 2009 3278 3284
21. S.J. Braeuer, C. Buneker, A. Mohr, and R.M. Zwacka Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells Mol. Cancer Res. 4 2006 715 728 (Pubitemid 44683312)
22. K.S. Ahn, G. Sethi, and B.B. Aggarwal Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products Mol. Pharmacol. 71 2007 209 219 (Pubitemid 46020991)
23. P. Lanuti Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3 Cell Res. 19 2009 1079 1089